| Code | 7890A | ||||||||||
| MA number | 68/0128/11-S | ||||||||||
| Product Form: | tbl flm 100x20 mg (obal HDPE) | ||||||||||
| MA Status: | D - Marketing Authorisation valid for an unlimited period | ||||||||||
| Type of procedure: | Decentralised | ||||||||||
| MAH, country: | Teva B.V., Netherland | ||||||||||
| Therapeutic Class: | 68 - ANTIPSYCHOTICA (NEUROLEPTICA) | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 36 | ||||||||||
| Route of admin.: | Oral use |
| Prescription Status: | Medicinal product subject to medical prescription. |
| Legal basis: | Article 10(1) generic application |
| MA issued: | 22.02.2011 |
| SPC: |
SPC_Olanzapin Actavis_07_2024.pdf
|
| PIL: |
PIL Olanzapin Actavis_07_2024.pdf
|
| Safety feature | Yes |
| Data update: | 07.06.2024 |
